Research Overview

The Depression Clinical and Research Program (DCRP), under the direction of Dr. Jonathan Alpert, is now considered one of the leading centers for the study of Unipolar Depressive Disorders worldwide. The successes of the DCRP in the field of depression research have not only informed clinical practice, but have also contributed to the development of new standards of care.

Over the years, the DCRP has comprised a large group of experienced researchers as well as promising young trainees and junior faculty, generating countless clinical reports, pilot studies, and large controlled trials. The staff at the DCRP has consistently obtained research funding from both the National Institutes of Mental Health and industry sources.

Ongoing research studies conducted at the DCRP:

  • Psychotherapy studies, including psychodynamic psychotherapy, cognitive-behavioral therapy (CBT), stress reduction therapy, culturally-focused counseling, and telepsychiatry
  • Medical trials for depression, including antidepressants and atypical antipsychotics
  • Studies targeting specific populations, such as college students, ethnic minority patients, patients with Parkinson’s disease, and patients with nicotine dependence
  • Non-medication treatment studies, including cranial electrical stimulation (CES), acupuncture, placebo, and a medication management system
  • Natural treatment studies, such as omega-3 fatty acids, vitamins, and probiotics
  • Non-treatment studies of various psychological and physical processes, including stress and aging, visual memory and object recognition, responses to reward and punishment, speech patterns, and fMRI.

If you would like to learn more about these studies and/or are interested in participating, please read more detailed descriptions of these trials here, or call us at 1-877-552-5837.

Back to Top